Advanced Medical Institute (AMI)
Advanced Medical Institute (AMI), through its wholly owned subsidiary, Advanced Medical Institute (AMI) Pty Limited, (AMI Australia) headquartered in Sydney, Australia, is a leading provider of treatment programs for Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse. AMI Australia operates 21 treatment clinics and sales centers in Australia and New Zealand, including a centralized call center in Australia, has more than 195 employees, including 47 medical personnel, and since its inception has provided treatment to more than 250,000 patients. AMI Australia and its predecessor company began treating erectile dysfunction patients successfully 6 years prior to the launch of Viagra, in 1999, in Australia.
Mr Vaisman claims almost 500,000 men over the past decade have responded to Advanced Medical Institute (AMI) billboard-sized promises of longer lasting sex. Last year AMI, registered as a public company on the US NASDAQ, posted an almost 50 per cent increase in gross profit, from $8million to $12million, in the July to September quarter alone - profit the company attributed to its more effective advertising campaigns (at a cost of $500,000 a quarter), increased brand name recognition, and the effectiveness of Advanced Medical Institute (AMI) products.
Vaisman says AMI nasal sprays have practically no side effects. The risk of priapism is no more prevalent with the use of injectibles than with more conventional treatments such as Viagra, he adds, while AMI's 24-hour hotline is available to advise in such emergencies. Mr Vaisman says Impotence Australia, one of Advanced Medical Institute (AMI) most vocal critics, is in direct competition and accepts sponsorship from large pharmaceutical companies such as Viagra's manufacturer, Pfizer.
Advanced Medical Institute (AMI) is a service provider company, which arranges for patients with sexual dysfunction and prostate problems in Australia, New Zealand, China and the United Kingdom to be provided with medical services, pharmaceuticals and associated clinical support services. On September 15, 2008, AMI Australia announced expansion of our operations to the United Kingdom where we opened up our treatment centers, contracts with independent doctors and pharmacies and began airing infomercials throughout the country.
Advanced Medical Institute (AMI) has argued that it would not take down the posters for the prescription AMI nasal spray, saying that "men have a right to know" how to perform better in bed. It told the Media Guardian that it felt it was important for all parties concerned that the campaign is able to run its course. Michael Spire, AMI Australia medical director, told the paper, “We must not overreact: this isn't the first time sex has been used in an advertising campaign. Even as we speak posters for [the film] Sex Drive are appearing all over London." He added that the company was very concerned that the ASA had called for the Advanced Medical Institute (AMI) campaign to be pulled before it had investigated the complaints.
AMI nasal Spray developed and patented by the Advanced Medical Institute (AMI). AMI are also based in New Zealand and now Europe under amieurope.co.uk. The nasal sprays developed by this company have been under a lot of scrutiny lately and this adds to all the controversy the company as a whole has attracted since its inception in Australia. Advanced Medical Institute (AMI) will now conduct business in the UK through its wholly owned subsidiary, AMI Clinic Limited (AVMD UK).
